Inventor
PAISNER DAVID A
US12 patents
⚠️ This page may combine multiple inventors who share the name “PAISNER DAVID A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIGNAL PHARM LLC
6 patentsUS9701643B2Jul 11, 2017
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC19 citations91
US10919865B2Feb 16, 2021
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC3 citations83
US10266500B2Apr 23, 2019
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC5 citations83
US10040770B2Aug 7, 2018
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC7 citations83
US11325890B2May 10, 2022
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC2 citations72
US12129237B2Oct 29, 2024
Substituted diaminocarboxamide and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith
SIGNAL PHARM LLC0 citations61
GUNIC ESMIR
4 patentsUS8173690B2May 8, 2012
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR21 citations90
US8193234B2Jun 5, 2012
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR13 citations83
US8633232B2Jan 21, 2014
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR7 citations82
US8242154B2Aug 14, 2012
Compounds, compositions and methods of using same for modulating uric acid levels
GUNIC ESMIR11 citations82